3Greven KM, Keyes JW Jr, Williams DW 3rd, et al. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2- deoxy-D-glucose [J]. Cancer, 1999,86( 1 ) : 114-118.
4Kresnik E, Mikosch P, Gallowitsch HJ, et al. Evaluation of head and neck cancer with tSF-FDG PET: a comparison with converntional methods [J]. Etar J Nucl Med, 2001,28(7): 816-821.
5Regelink G, Brouwer J, de Bree R, et al. Detection of unknown primary tumors and distant metastases in patients with cervical metastases : value of FDG-PET versus conventional modalities [J]. Eur J Nucl Med Mol Imaging, 2002,29 ( 8 ) : 1024-1030.
6Paul SA, Stoeckli S J, yon Schulthess GK, et al. FDG PET and PET/CT for the detection of the primary tumor in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary [J]. Eur Arch Otorhinolaryngol, 2007,264 (2) : 189-195.
7Rusthoven KE, Koshy M, Paulino AC. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor [J]. Cancer, 2004,101 ( 11 ) : 2641-2649.
8Gutzeit A, Antoch G, Kuhl H, et al. Unknown primary tumors : detection with Dual-Modality PET/CT--nitial experience [J]. Radiology, 2005,234( 1 ) : 227-234.
9Yi JS,Kim JS,Lee JH,et al. 18F- FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma[J]. J Surg Oncol,2012,106(6) 708 - 712.
10Lee SH, Huh SH,Jin SM,et al. Diagnostic value of only 18F- {luorodeocyglucose positron emissiontomography/computed tomography- positive lymph nodes in head and neck squamous cell carcinoma[J]. Otolaryngol Head Neck Surg, 2012, 147 (4) : 692 - 698.
4Senti A, Bree R, Golding RP, et al. Interobserver variability in chest CT and whole body FDG-PET screening for distant metastases in head and neck cancer patients[J]. Mol Imaging Biol, 2014, 13(2): 385-390.
5Kyzas PA, Evangelou E, Denaxa-Kyza D. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta- analysis[J]. J Natl Cancer Inst , 2008, 100(10):712-720.
6Kostakoglu L, Fardanesh R, Posner M, et al. Early detection of re- current disease by FDG-PET/CT leads to management changes in patients with squamous cell cancer of the head and neck[J]. Oncol, 2013, 18(10): 1108-1117.
7VanderWalde NA, Fleming M, Weiss J, et al. Treatment of older pa- tients with head and neck cancer: a review[J]. Oncol, 2013, 18(5): 568-578.
